Vericel Corporation (VCEL) Stock Analysis

VCEL

Market Closed

Vericel Corporation

NASDAQHealthcare Biotechnology

398 employees

CEO: Dominick C. Colangelo

Founded: 1997

$46.78

+$0.00(+NaN%)

Market Cap

2.39B

Beta

1.07

52W Range

N/A

Dividend Yield

0.00%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

VCEL Price Chart

Historical price performance

Loading MCI price data...

MarketCI Investment Signals

AI-synthesized investment signal for VCEL built from valuation, fundamentals, sentiment, and risk models

Investment Signal

Hold

Pass %

57.14%

Score

4/7

Fair Value Estimate

Cash flow analysis • Multiple methods

-$17.90

AI Price Target

Machine learning • Price prediction

$44.94

Market Sentiment

News & social media analysis

0.00

Value Investor Price

Classic value analysis

$0.00

Financial Health

Bankruptcy risk assessment

8.98

Quality Score

Financial strength rating

7.00

AI Investment Grade

Deep analysis of filings & news

65.00

Key Investment Highlights

Important factors affecting VCEL investment thesis

Due Diligence Analysis

Investment criteria assessment and scoring

Overall Assessment

57.50% Good

Conditions Met

23.00/40.00

Due Diligence Score

57.50%

Due Diligence Conditions

Investment analysis conditions and results


	Pass
	Fail
	Pass
	Pass
	Pass
	Pass

Showing 1 to 6 of 46 conditions